Ivermectin Study’s Negative Conclusion is at Odds With Its Findings of Significant Clinical Benefit

Will Jones

A new study on cheap, repurposed Covid treatment ivermectin has concluded that its findings “do not support the use of ivermectin to treat mild to severe forms of COVID-19”. However, this conclusion is at odds with its findings.

… The study is a follow-up to an earlier, smaller study which showed promise. However, the promise has not, the authors say, been borne out.

… Despite this downbeat assessment, the new study did actually find a significant 32% improvement in ivermectin hospital patients achieving complete recovery, with 37% of ivermectin patients vs 28% of placebo patients achieving the outcome.

Latest articles

Non-GMO Project Is it possible to create a non-GMO product using genetic...
Carlos A. Monteiro Orthodox teaching and practice on nutrition and health almost...
What They Don’t Want to Tell You About Genetically Modified Crops and...
Environmental Health Symposium While we were distracted with Covid-19, lockdowns, mask mandates,...
Royal Lee “There is only one test for safety and wholesomeness in...
Weston A. Price Foundation WE HAVE ALWAYS PROCESSED OUR FOOD; this is...

Thank you!

The form has been submitted successfully!